See where we are at in our product development pipeline! This consists of our internal and international co-development collaborations with specific focus on vaccines, cell therapy, new modalities for oncology, rare/orphan drugs, genetic diseases.
We uphold this ethos that permeates in every aspect and level of our organization ensuring the future of medicine through sustainable business.
For instances in which we are master licensee, we work via a franchisee model technology transferring out co-developed products.
We work closely on market access and reimbursement with non-governmental organizations (NGOs), government-linked companies, hospital systems via our growing network of clinicians in ASEAN/ANZ and South Asia.